GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Synthetic MR AB (XSAT:SYNT) » Definitions » 5-Year Yield-on-Cost %

Synthetic MR AB (XSAT:SYNT) 5-Year Yield-on-Cost % : 0.00 (As of May. 24, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Synthetic MR AB 5-Year Yield-on-Cost %?

Synthetic MR AB's yield on cost for the quarter that ended in Mar. 2024 was 0.00.


The historical rank and industry rank for Synthetic MR AB's 5-Year Yield-on-Cost % or its related term are showing as below:


During the past 12 years, Synthetic MR AB's highest Yield on Cost was 1.14. The lowest was 0.20. And the median was 0.53.


XSAT:SYNT's 5-Year Yield-on-Cost % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.4
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Synthetic MR AB's 5-Year Yield-on-Cost %

For the Health Information Services subindustry, Synthetic MR AB's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synthetic MR AB's 5-Year Yield-on-Cost % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Synthetic MR AB's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Synthetic MR AB's 5-Year Yield-on-Cost % falls into.



Synthetic MR AB 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Synthetic MR AB is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Synthetic MR AB  (XSAT:SYNT) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Synthetic MR AB 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Synthetic MR AB's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Synthetic MR AB (XSAT:SYNT) Business Description

Traded in Other Exchanges
N/A
Address
Storgatan 11, Linkoping, SWE, SE-582 23
Synthetic MR AB develops innovative software solutions for Magnetic Resonance Imaging that supports shorter exam times and delivers more information to the clinician. Its product is available in different packages. SyMRI IMAGE provides high MRI workflows and enables automatic segmentation of brain tissue, providing objective decision support, MAGiC is a customer-specific version of SyMRI IMAGE marketed and sold by GE Healthcare under a licence agreement, SyMRI NEURO includes contrast images, biomarker segmentation, volumetric measurements of brain tissues and quantitative parametric maps, and SyMRI Research Edition includes contrast images, volumetric measurements and quantitative maps to provide more information to the researcher.

Synthetic MR AB (XSAT:SYNT) Headlines

From GuruFocus

Interim CEO Invests in IT Company

By Jennifer Chiou Jennifer Chiou 12-07-2016

Syntel enters definitive agreement to be acquired by Atos S.E.

By GlobeNewswire GlobeNewswire 07-22-2018

Third Avenue Management Comments on Syntel

By Holly LaFon 07-02-2013

Syntel Inc. (SYNT) CEO and President Prashant Ranade sells 3,000 Shares

By GuruFocus Research GuruFocus Editor 12-17-2010

Syntel enters definitive agreement to be acquired by Atos S.E.

By Marketwired Marketwired 07-22-2018

Syntel: A contrarian's delight

By nicklaskastrup Dhandoisms 05-15-2015

RM LAW Announces Investigation of Syntel, Inc.

By PRNewswire PRNewswire 07-26-2018

Syntel Inc. Reports Operating Results (10-K)

By gurufocus 10qk 03-03-2011

Insiders Are Investing in Syntel

By Kyle Ferguson Kyle Ferguson 04-27-2017